Activation of hepatic stellate cells in liver tissue of patients with fulminant liver failure after treatment with bioartificial liver.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Human Pathology

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/HUPA.2001.29681PMID 11774171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.

  2000cited by this paper
• Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure.

  2000cited by this paper
• Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.

  2000cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Peroxisome proliferator‐activated receptor γ transcriptional regulation is involved in platelet‐derived growth factor–induced proliferation of human hepatic stellate cells

  2000cited by this paper
• HEPATOLOGY: MICROCIRCULATION AND PATHOGENESIS OF ALCOHOLIC LIVER INJURY Molecular mechanism of the reversibility of hepatic fibrosis: With special reference to the role of matrix metalloproteinases

  2000cited by this paper
• Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki‐67 expression

  1999cited by this paper
• Biology of Hepatic Stellate Cells and Their Possible Relevance in the Pathogenesis of Portal Hypertension in Cirrhosis

  1999cited by this paper
• Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.

  1999cited by this paper
• Evaluation of fibrosis and hepatitis C.

  1999cited by this paper
• Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy

  1999cited by this paper
• Molecular regulation of hepatic fibrogenesis.

  1998cited by this paper
• Hepatic stellate cells

  1998cited by this paper
• The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide

  1997cited by this paper
• Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.

  1997cited by this paper
• Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts

  1997cited by this paper
• Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

  1997cited by this paper
• Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

  1996cited by this paper
• Hepatic stellate cells.

  1996cited by this paper
• Acute liver failure.

  1993cited by this paper
• Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.

  1991cited by this paper
• Phase I clinical trials.

  1977cited by this paper

• Acute Viral Hepatitis

  2020cites this paper
• Acute Viral Hepatitis

  2020cites this paper
• Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure

  2018cites this paper
• Stellate Cells in Hepatic Immunological Tolerance

  2015cites this paper
• Systematic review: extracorporeal bio-artificial liver-support system for liver failure

  2012cites this paper
• Distinct Mechanism of Small‐for‐Size Fatty Liver Graft Injury—Wnt4 Signaling Activates Hepatic Stellate Cells

  2010cites this paper
• Hepatic stellate cells in biopsies from liver allografts with acute rejection.

  2006cites this paper
• Artificial Liver: Present or Future?

  2002cites this paper
• evaluation of extracorporeal bioartificial liver support system for the treatment of liver failure

  year unknowncites this paper